Lv6
2840 积分 2022-09-19 加入
In vivo CAR engineering for immunotherapy
14小时前
待确认
From Concept to Cure: The Evolution of CAR-T Cell Therapy
20小时前
待确认
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
1天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3天前
已完结
Antibody–Bottlebrush Conjugates Unlock Diverse Payloads for Targeted Cancer Therapy
19天前
已完结
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
1个月前
已完结
Antibody–bottlebrush prodrug conjugates for targeted cancer therapy
1个月前
已完结
Engineered Virus‐Like Nanoparticles Enable Multimodal Protein Degradation for Enhanced Tumor Therapy
1个月前
已完结
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells
2个月前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
2个月前
已完结
皖公网安备34019202002308
